Modulation of the immune response induced by gene electrotransfer of a hepatitis C virus DNA vaccine in nonhuman primates

Journal of Immunology

Volumn 177, Issue 10, 2006, Pages 7462-7471

  Capone, Stefania ^a   Zampaglione, Immacolata ^a   Vitelli, Alessandra ^a   Pezzanera, Monica ^a   Kierstead, Lisa ^b   Burns, Janine ^b   Ruggeri, Lionello ^a   Arcuri, Mirko ^a   Cappelletti, Manuela ^a   Meola, Annalisa ^a   Ercole, Bruno Bruni ^a   Tafi, Rosalba ^a   Santini, Claudia ^a   Luzzago, Alessandra ^a   Fu, Tong Ming ^b   Celloca, Stefano ^a   Ciliberto, Gennaro ^a   Cortese, Riccardo ^a   Nicosia, Alfredo ^a   Fattori, Elena ^a   Folgori, Antonella ^a   more..

^a IRBM   (Italy)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; HEPATITIS C VACCINE; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5B; UNCLASSIFIED DRUG; VIRUS DNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHIMPANZEE; CONTROLLED STUDY; DRUG POTENCY; ENZYME LINKED IMMUNOSPOT ASSAY; GENE ELECTROTRANSFER; GENE TRANSFER; HEPATITIS C; HEPATITIS C VIRUS; IMMUNOMODULATION; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; T LYMPHOCYTE ACTIVATION; VACCINATION; VACCINE PRODUCTION; VIRUS MORPHOLOGY; VIRUS VECTOR;

EID: 33750796905     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.10.7462     Document Type: Article

References (50)

1. Gurunathan, S., D. M. Klinman, and R. A. Seder. 2000. DNA vaccines: immunology, application, and optimization. Annu. Rev. Immunol. 18: 927-974.
2. Wang, R., D. L. Doolan, T. P. Le, R. C. Hedstrom, K. M. Coonan, Y. Charoenvit, T. R. Jones, P. Hobart, M. Margalith, J. Ng, et al. 1998. Induction of antigen-specific cytotoxic T lymphocytes in humans by a malaria DNA vaccine. Science 282: 476-480.
3. Calarota, S., G. Bratt, S. Nordlund, J. Hinkula, A. C. Leandersson, E. Sandstrom, and B. Wahren. 1998. Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients. Lancet 351: 1320-1325.
4. MacGregor, R. R., J. D. Boyer, K. E. Ugen, K. E. Lacy, S. J. Gluckman, M. L. Bagarazzi, M. A. Chattergoon, Y. Baine, T. J. Higgins, R. B. Ciccarelli, et al. 1998. First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. J. Infect. Dis. 178: 92-100.
5. Hejdeman, B., A. C. Bostrom, R. Matsuda, S. Calarota, R. Lenkei, E. L. Fredriksson, E. Sandstrom, G. Bratt, and B. Wahren. 2004. DNA immunization with HIV early genes in HIV type 1-infected patients on highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 20: 860-870.
6. MacGregor, R. R., R. Ginsberg, K. E. Ugen, Y. Baine, C. U. Kang, X. M. Tu, T. Higgins, D. B. Weiner, and J. D. Boyer. 2002. T cell responses induced in normal volunteers immunized with a DNA-based vaccine containing HIV-1 env and rev. AIDS 16: 2137-2143.
7. Lemieux, P. 2002. Technological advances to increase immunogenicity of DNA vaccines. Expert Rev. Vaccines 1: 85-93.
8. O'Hagan, D. T., M. Singh, C. Dong, M. Ugozzoli, K. Berger, E. Glazer, M. Selby, M. Wininger, P. Ng, K. Crawford, et al. Cationic microparticies are a potent delivery system for a HCV DNA vaccine. 2004. Vaccine 23: 672-680.
9. Otten, G. R., M. Schaefer, B. Doe, H. Liu, I. Srivastava, J. Megede, J. Kazzaz, Y. Lian, M. Singh, M. Ugozzoli, et al. 2005. Enhanced potency of plasmid DNA microparticle human immunodeficiency virus vaccines in rhesus macaques by using a priming-boosting regimen with recombinant proteins. J. Virol. 79: 8189-8200.
10. Aihara, H., and J. Miyazaki. 1998. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16: 867-870.
11. Mir, L. M., M. F. Bureau, J. Gehl, R. Rangara, D. Rouy, J. M. Caillaud, P. Delaere, D. Branellec, B. Schwartz, and D. Scherman. 1999. High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc. Natl. Acad. Sci. USA 96: 4262-4267.
12. Rizzuto, G., M. Cappelletti, D. Maione, R. Savino, D. Lazzaro, P. Costa, I. Mathiesen, R. Cortese, G. Ciliberto, R. Laufer, et al. 1999. Efficient and regulated erythropoietin production by naked DNA injection and muscle electroporation. Proc. Natl. Acad. Sci. USA 96: 6417-6422.
13. Fattori, E., N. La Monica, G. Ciliberto, and C. Toniatti. 2003. Electro-gene transfer: a new approach for muscle gene delivery. In Synthetic DNA Delivery Systems. D. Luo and M. Saltzman, eds. Eurekah.com and Kluwer Academic/Plenum Publishers, New York, pp. 71-79.
14. Zucchelli, S., S. Capone, E. Fattori, A. Folgori, A. Di Marco, D. Casimiro, A. J. Simon, R. Laufer, N. La Monica, R. Cortese, and A. Nicosia. 2000. Enhancing B and T cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer. J. Virol. 74: 11598-11607.
15. Zampaglione, I., M. Arcuri, M. Cappelletti, G. Ciliberto, G. Perretta, A. Nicosia, N. La Monica, and E. Fattori. 2005. In vivo DNA gene-electro transfer: a systematic analysis of different electrical parameters. J. Gene Med. 7: 1475-1481.
16. Tomei, L., C. Failla, E. Santolini, R. De Francesco, and N. La Monica. 1993. NS3 is a serine protease required for processing of hepatitis C virus polyprotein. J. Virol. 67: 4017-4026.
17. Capone, S., A. Meola, B. B. Ercole, A. Vitelli, M. Pezzanera, M. E. Davies, R. Tafi, C. Santini, A. Luzzago, T. Fu, et al. 2006. A novel Ad6 based HCV vector that overcomes pre-existing anti-Ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques. J. Virol. 80: 1688-1699.
18. Mottola, G., G. Cardinali, A. Ceccacci, C. Trozzi, L. Bartholomew, M. R. Torrisi, E. Pedrazzini, S. Bonatti, and G. Migliaccio. 2002. Hepatitis C virus nonstructural proteins are localized in a modified endoplasmic reticulum of cells expressing viral subgenomic replicons. Virology 293: 31-43.
19. Takamizawa, A., C. Mori, I. Fuke, S. Manabe, S. Murakami, J. Fujita, E. Onishi, T. Andoh, I. Yoshida, and H. Okayama. 1991. Structure and organization of the hepatitis C virus genome isolated from human carriers. J. Virol. 65: 1105-1113.
20. Zhang, Z. Q., W. A. Schleif, D. R. Casimiro, L. Handt, M. Chen, M. E. Davies, X. Liang, T. M. Fu, A. Tang, K. A. Wilson, et al. 2004. The impact of early immune destruction on the kinetics of postacute viral replication in rhesus monkey infected with the simian-human immunodeficiency virus 89.6P. Virology 320: 75-84.
21. Fu, T. M., D. C. Freed, W. L. Trigona, L. Guan, L. Zhu, R. Long, N. V. Persaud, K. Manson, S. Dubey, and J. W. Shiver. 2001. Evaluation of cytotoxic T lymphocyte responses in human and nonhuman primate subjects infected with human immunodeficiency virus type 1 or simian/human immunodeficiency virus. J. Virol. 75: 73-82.
22. + T cell proliferation during acute HCV infection leads to failure of viral clearance. Gut 55: 1012-1019.
23. + T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained. Eur. J. Immunol. 30: 2479-2487.
24. + T cells in acute and chronic hepatitis C. Hepatology 37: 1189-1198.
25. Wedemeyer, H., X. S. He, M. Nascimbeni, A. R. Davies, H. B. Greenberg. J. H. Hoofnagle, T. J. Liang, H. Alter, and B. Reermann. 2002. Impaired effector function of hepatitis C virus-specific CD8 T cells in chronic hepatitis C virus infection. J. Immunol. 169: 3447-3458.
26. Bowen, D. G., and C. M. Walker. 2005. Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436: 946-952.
27. + T cells: implications for vaccine development. Hepatology 30: 1088-1098.
28. Spada, E., A. Mele, A. Berton, L. Ruggeri, L. Ferrigno, A. Garbuglia, M. Perrone, G. Girelli, P. del Porto, E. Piccolella, et al. 2004. Multi-specific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance. Gut 53: 1673-1681.
29. Alter, M. J. 1999. Hepatitis C virus infection in the United States. J. Hepatology 31(S1): 88-91.
30. zur Megede, J., M. C. Chen, B. Doe, M. Schaefer, C. E. Greer, M. Selby, G. R. Otten, and S. W. Barnett. 2000. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J. Virol. 74: 2628-2635.
31. Casimiro, D. R., A. Tang, H. C. Perry, R. S. Long, M. Chen, G. J. Heidecker, M. E. Davies, D. C. Freed, N. V. Persaud, S. Dubey, et al. 2002. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. J. Virol. 76: 185-194.
32. Widera, G., M. Austin, D. Rabussay, C. Goldbeck, S. W. Barnett, M. Chen, L. Leung, G. R. Otten, K. Thudium, M. J. Selby, and J. B. Ulmer. 2000. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J. Immunol. 164: 4635-4640.
33. Kadowaki, S., Z. Chen, H. Asanuma, C. Aizawa, T. Kurata, and S. Tamura. 2000. Protection against influenza virus infection in mice immunized by administration of hemagglutinin-expressing DNAs with electroporation. Vaccine 18: 2779-2788.
34. Babiuk, S., M. E. Baca-Estrada, M. Foldvari, M. Storms, D. Rabussay, G. Widera, and L. A. Babiuk. 2002. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20: 3399-3408.
35. Babiuk, L. A., R. Pontarollo, S. Babiuk, B. Loehr, and S. van Drunen Littel-van den Hurk. 2003. Induction of immune responses by DNA vaccines in large animals. Vaccine 21: 649-658.
36. Otten, G., M. Schaefer, B. Doe, H. Liu, I. Srivastava, J. zur Megede, D. O'Hagan, J. Donnelly, G. Widera, D. Rabussay, et al. 2004. Enhancement of DNA vaccine potency in rhesus macaques by electroporation. Vaccine 22: 2489-2493.
37. Kaech, S. M., E. J. Wherry, and R. Ahmed. 2002. Effector and memory T cell differentiation: implications for vaccine development. Nat. Rev. Immunol. 2: 251-262.
38. Polakos, N. K., D. Drane, J. Cox, P. Ng, M. J. Selby, D. Chien, D. T. O'Hagan, M. Houghton, and X. Paliard. 2001. Characterization of hepatitis C virus core-specific immune responses primed in rhesus macaques by a nonclassical ISCOM vaccine. J. Immunol. 166: 3589-3598.
39. Silvera, P., J. R. Savary, V. Livingston, J. White, K. H. Manson, M. H. Wyand, P. L. Salk, R. B. Moss, and M. G. Lewis. 2004. Vaccination with gp120-depleted HIV-1 plus immunostimulatory CpG oligodeoxynucleotides in incomplete Freund's adjuvant stimulates cellular and humoral immunity in rhesus macaques. Vaccine 23: 827-839.
40. + T cells are required for protection from persistent hepatitis C virus infection. J. Exp. Med. 197: 1645-1655.
41. Missale, G., R. Bertoni, V. Lamonaca, A. Valli, M. Massari, C. Mori, M. G. Rumi, M. Houghton, F. Fiaccadori, and C. Ferrari. 1996. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J. Clin. Invest 98: 706-714.
42. Botarelli, P., M. R. Brunetto, M. A. Minutello, P. Calvo, D. Unutmaz, A. J. Weiner, Q. L. Choo, J. R. Shuster, G. Kuo, F. Bonino, et al. 1993. T lymphocyte response to hepatitis C virus in different clinical courses of infection. Gastroenterology 104: 580-587.
43. + T cell response in acute hepatitis C. Gastroenterology 117: 933-941.
44. Shedlock, D. J., and H. Shen. 2003. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science 300: 337-339.
45. Sun, J. C., and M. J. Bevan. 2003. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science 300: 339-342.
46. Choo, Q. L., G. Kuo, R. Ralston, A. Weiner, D. Chien, G. Van Nest, J. Han, K. Berger, K. Thudium, C. Kuo, et al. 1994. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc. Natl. Acad. Sci. USA 91: 1294-1298.
47. Forns, X., P. J. Fayette, X. Ma, W. Satterfield, G. Eder, I. K. Mushahwar, S. Govindarajan, H. L. Davis, S. U. Emerson, R. H. Purcell, and J. Bukh. 2000. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV. Hepatology 32: 618-625.
48. Rollier, C., E. Depla, J. A. Drexhage, E. J. Verschoor, B. E. Verstrepen, A. Fatmi, C. Brinster, A. Fournillier, J. A. Whelan, M. Whelan, et al. 2004. Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T helper immune response. J. Virol. 78: 187-196.
49. Houghton, M., and S. Abrignani. 2005. Prospects for a vaccine against the hepatitis C virus. Nature 436: 961-966.
50. Folgori, A., S. Capone, L. Ruggeri, A. Meola, E. Sporeno, B. Bruni Ercole, M. Pezzanera, R. Tafi, M. Arcuri, A. Luzzago, et al. 2006. A T cell based HCV vaccine eliciting protective anti-viral immunity against heterologous challenge in chimpanzees. Nat. Med. 12: 190-197.